Table 2.
Comparison of demographics for patients with localized ESOS who received CT vs no CT, and patients who received RT vs no RT
| No Chemotherapy N=190 |
Received Chemotherapy N=178 |
p-value |
No Radiotherapy N=218 |
Received Radiotherapy N=152 |
p-value | ||
|---|---|---|---|---|---|---|---|
|
Age (yrs) |
Median | 64 | 55 | <0.001* | 58 | 59 | 0.20 |
| Range | 21 – 88 | 19 – 79 | 19 – 88 | 21 – 88 | |||
| 19–40 years | 26 (42.6) | 35 (57.4) | <0.001* | 46 (75.4) | 15 (24.6) | 0.003* | |
| 41–65 years | 78 (42.4) | 106 (57.6) | 95 (51.6) | 89 (48.4) | |||
| >65 years | 86 (69.9) | 37 (30.1) | 77 (61.6) | 48 (38.4) | |||
| Sex | Male | 108 (56.8) | 108(60.7) | 0.46 | 121 (55.5) | 96 (63.2) | 0.16 |
| Female | 82 (43.2) | 70 (39.3) | 97 (44.5) | 56 (36.8) | |||
| Depth of Tumour | Superficial | 47 (24.7) | 23 (13.3) | 0.007 * | 49 (22.6) | 22 (14.9) | 0.08 |
| Deep | 143 (75.3) | 150 (86.7) | 168 (77.4) | 126 (85.1) | |||
|
Maximal Tumor Diameter (cm) 19 NAs |
Median | 8.1 | 8.8 | 0.32 | 8.4 | 9.1 | 0.40 |
| Range | 1.4 – 45.0 | 1.0 – 42.0 | 1.0 – 45.0 | 1.0 – 42.0 | |||
| Margin Status | Negative (R0) | 156 (83.4) | 151 (86.3) | 0.58 | 187 (87.4) | 122 (81.3) | 0.27 |
| Microscopi c positive (R1) | 19 (10.2) | 17 (9.7) | 17 (7.9) | 19 (12.7) | |||
| Gross positive (R2) | 12 (6.4) | 7 (4.0) | 10 (4.7) | 9 (6.0) |
(NA = not available)